help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology Vol. 2, No. 7 591-598
doi:10.1210/mend-2-7-591
Copyright © 1988 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murphy, P. R.
Right arrow Articles by Friesen, H. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murphy, P. R.
Right arrow Articles by Friesen, H. G.

Fibroblast Growth Factor Messenger Ribonucleic Acid Expression in a Human Astrocytoma Cell Line: Regulation by Serum and Cell Density

Paul R. Murphy, Reiko Sato, Yuji Sato and Henry G. Friesen

Department of Physiology, Faculty of Medicine, University of Manitoba Winnipeg, Manitoba, Canada R3E OW3

Address requests for reprints to: Dr. Paul R. Murphy, Department of Physiology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada R3E 0W3.

Abstract

A human astrocytoma cell line, U87-MG, synthesizes a growth factor which is structurally related to basic fibroblast growth factor (bFGF) by several criteria: 1) it binds to heparin-Sepharose and elutes at 2 M NaCI; 2) it cross-reacts with N-terminal specific anti-bFGF antibodies; 3) it is a potent mitogen for rabbit fetal chondrocytes. Northern blotting analysis of total RNA reveals that the cells express high levels of two bFGF mRNA transcripts of 7 and 3.7 kilobase in size. The levels of both transcripts rise rapidly (within 3 h) after addition of serum to serum-deprived cultures, reach a maximum within 6–12 h and remain elevated for at least 24 h. Basic FGF mRNA expression was low in confluent cultures but was increased after replating at sparse density. Transcript levels began to increase 4 h after plating, reaching a maximum (7-fold above confluent cells) within 24 h. The rise in bFGF mRNA levels was preceded by a rapid rise in c-myc expression which peaked 8 h after plating and then declined. The level of bFGF mRNA expression began to decline by 48 h, before any detectable increase in cell number, and returned to control levels when the cells reached confluence after 10 days. The level of transforming growth factor β mRNA, which is also expressed in these cells, was not affected by cell density. The effects of density on bFGF mRNA levels were not duplicated by culturing low density cells in conditioned medium from confluent cultures or in medium containing 10 ng/ml bFGF.

These findings indicate that bFGF expression is tightly regulated by cell density, and may be directly controlled by cell-cell contact or by factors present in the extracellular matrix. The transient peak of expression shortly after plating suggests that bFGF expression is closely associated with factors regulating cell cycle progression, and may help to explain the low levels of expression detected in differentiated normal tissues.

FOOTNOTES

This work was supported by grants from MRC and National Cancer Institute of Canada.

We are grateful to Drs. Catherine Too and R. P. C. Shiu for critical reading of the manuscript, and to Dr. Leigh Murphy for helpful technical suggestions. The secretarial assistance of A. Macintosh is greatly appreciated.

Received for publication December 23, 1987. Accepted for publication March 17, 1988.




This article has been cited by other articles:


Home page
EndocrinologyHome page
M. G. Sabbieti, L. Marchetti, C. Abreu, A. Montero, A. R. Hand, L. G. Raisz, and M. M. Hurley
Prostaglandins Regulate the Expression of Fibroblast Growth Factor-2 in Bone
Endocrinology, January 1, 1999; 140(1): 434 - 444.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
B. Galy, A. Maret, A.-C. Prats, and H. Prats
Cell Transformation Results in the Loss of the Density-dependent Translational Regulation of the Expression of Fibroblast Growth Factor 2 Isoforms
Cancer Res., January 1, 1999; 59(1): 165 - 171.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
M. Litwin, K. Clark, L. Noack, J. Furze, M. Berndt, S. Albelda, M. Vadas, and J. Gamble
Novel Cytokine-independent Induction of Endothelial Adhesion Molecules Regulated by Platelet/Endothelial Cell Adhesion Molecule (CD31)
J. Cell Biol., October 6, 1997; 139(1): 219 - 228.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
R Serra and H. Moses
pRb is necessary for inhibition of N-myc expression by TGF-beta 1 in embryonic lung organ cultures
Development, January 9, 1995; 121(9): 3057 - 3066.
[Abstract] [PDF]


Home page
DevelopmentHome page
L Sherman, K. Stocker, R Morrison, and G Ciment
Basic fibroblast growth factor (bFGF) acts intracellularly to cause the transdifferentiation of avian neural crest-derived Schwann cell precursors into melanocytes
Development, January 8, 1993; 118(4): 1313 - 1326.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1988 by The Endocrine Society